Status: Not yet recruiting
Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus
The purpose of this research is to investigate the efficacy of nemolizumab in the treatment of adults with moderate to severe chronic hepatic pruritus.
Participants needed: 15
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Mayo ClinicUpdated: Sep 28, 2026Locations: 1
Eligibility criteria
Cholestatic pruritus secondary primary biliary sclerosis (PBS) or primary sclero... [+4]
Pruritus due to a primary inflammatory skin dermatosis or other forms of psychog... [+11]